Literature DB >> 23996239

Implication of tumor stem-like cells in the tumorigenesis of sporadic paraganglioma.

Yueming Yang1, Liandi Guo, Fan Yang, Qing Huang, Fuping Zhang, Hongwei Ma, Hedong Li, Kaixuan Yang, Jiangyan Lou, Cong Liu.   

Abstract

It is commonly believed that paragangliomas are rare tumors arising from the neural crest-derived chromaffin cells. Although it has been speculated that paraganglioma is related to stem cell origin, there has been lack of direct evidence demonstrating the presence of (neural) stem cells in these tumor tissues. In this study, we found a subgroup of human paraganglioma from ten clinical samples displayed definitive markers of CD133 and/or nestin, the fundamental features of neural stem cell capable of self-renewal and differentiation. A panel of lineage-specific markers was also manifest in some of these tumors, consistent with the hierarchical and heterogeneous nature of these tumors. These observations strongly suggest that at least some forms of paraganglioma maintain tumor stem-like cells (TSCs) that potentially contribute to the histologic complexity of human paraganglioma. Finally, we found that the genomic DNA structure becomes highly unstable in tumor cells of paraganglioma, indicating the loss of tight control of genomic surveillance system be an important transitory event from normal multi-potent tissue stem cells to TSCs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23996239     DOI: 10.1007/s12032-013-0659-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  26 in total

Review 1.  Multipotentiality of the neural crest.

Authors:  Nicole M Le Douarin; Elisabeth Dupin
Journal:  Curr Opin Genet Dev       Date:  2003-10       Impact factor: 5.578

2.  Multipotent cell fate of neural crest-like cells derived from embryonic stem cells.

Authors:  Tsutomu Motohashi; Hitomi Aoki; Kairi Chiba; Naoko Yoshimura; Takahiro Kunisada
Journal:  Stem Cells       Date:  2006-10-12       Impact factor: 6.277

3.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions.

Authors:  Vassilis G Gorgoulis; Leandros-Vassilios F Vassiliou; Panagiotis Karakaidos; Panayotis Zacharatos; Athanassios Kotsinas; Triantafillos Liloglou; Monica Venere; Richard A Ditullio; Nikolaos G Kastrinakis; Brynn Levy; Dimitris Kletsas; Akihiro Yoneta; Meenhard Herlyn; Christos Kittas; Thanos D Halazonetis
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

4.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

5.  Multifocal presentation of gangliocytic paraganglioma in the mediastinum and esophagus.

Authors:  David M Weinrach; Kim L Wang; Matthew G Blum; Anjana V Yeldandi; William B Laskin
Journal:  Hum Pathol       Date:  2004-10       Impact factor: 3.466

6.  Generation of neural crest-derived peripheral neurons and floor plate cells from mouse and primate embryonic stem cells.

Authors:  Kenji Mizuseki; Tatsunori Sakamoto; Kiichi Watanabe; Keiko Muguruma; Makoto Ikeya; Ayaka Nishiyama; Akiko Arakawa; Hirofumi Suemori; Norio Nakatsuji; Hiroshi Kawasaki; Fujio Murakami; Yoshiki Sasai
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-30       Impact factor: 11.205

7.  Gangliocytic paraganglioma arising from mature cystic teratoma of the ovary.

Authors:  Ali Mahdavi; Boris Silberberg; Vinay K Malviya; Alan H Braunstein; Joan Shapiro
Journal:  Gynecol Oncol       Date:  2003-08       Impact factor: 5.482

8.  Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells.

Authors:  Gabsang Lee; Hyesoo Kim; Yechiel Elkabetz; George Al Shamy; Georgia Panagiotakos; Tiziano Barberi; Viviane Tabar; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2007-11-25       Impact factor: 54.908

9.  CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines.

Authors:  Amy M McCord; Muhammad Jamal; Eli S Williams; Kevin Camphausen; Philip J Tofilon
Journal:  Clin Cancer Res       Date:  2009-08-11       Impact factor: 12.531

Review 10.  An oncogene-induced DNA damage model for cancer development.

Authors:  Thanos D Halazonetis; Vassilis G Gorgoulis; Jiri Bartek
Journal:  Science       Date:  2008-03-07       Impact factor: 47.728

View more
  3 in total

1.  Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib.

Authors:  Fabio Verginelli; Silvia Perconti; Simone Vespa; Francesca Schiavi; Sampath Chandra Prasad; Paola Lanuti; Alessandro Cama; Lorenzo Tramontana; Diana Liberata Esposito; Simone Guarnieri; Artenca Sheu; Mattia Russel Pantalone; Rosalba Florio; Annalisa Morgano; Cosmo Rossi; Giuseppina Bologna; Marco Marchisio; Andrea D'Argenio; Elisa Taschin; Rosa Visone; Giuseppe Opocher; Angelo Veronese; Carlo T Paties; Vinagolu K Rajasekhar; Cecilia Söderberg-Nauclér; Mario Sanna; Lavinia Vittoria Lotti; Renato Mariani-Costantini
Journal:  Acta Neuropathol       Date:  2018-01-05       Impact factor: 17.088

2.  Radiosensitization of Clioquinol Combined with Zinc in the Nasopharyngeal Cancer Stem-like Cells by Inhibiting Autophagy in Vitro and in Vivo.

Authors:  Yuan Ke; Chaoyan Wu; Yifei Zeng; Mengge Chen; Yonghong Li; Conghua Xie; Yunfeng Zhou; Yahua Zhong; Haijun Yu
Journal:  Int J Biol Sci       Date:  2020-01-14       Impact factor: 6.580

3.  Succinate Dehydrogenase Complex Iron Sulfur Subunit B (SDHB) Immunohistochemistry in Pheochromocytoma, Head and Neck Paraganglioma, Thoraco-Abdomino-Pelvic Paragangliomas: Is It a Good Idea to Use in Routine Work?

Authors:  Aylin Ege Gul; Sevinc Hallac Keser; Nagehan Ozdemir Barisik; Yesim Saliha Gurbuz; Sibel Sensu; Nusret Erdogan
Journal:  Asian Pac J Cancer Prev       Date:  2021-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.